No definition available.
Adenocarcinoma and Papillary adenocarcinoma of kidney
C3_KIDNEY_PAPILLARYADENO
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
386 |
4. Check minimum number of eventsNone |
386 |
5. Include endpointsNone |
386 |
6. Filter based on genotype QC (FinnGen only) |
367 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Adenocarcinoma and Papillary adenocarcinoma of kidney
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of kidney, except renal pelvis
- Malignant neoplasm of urinary organs
- Malignant neoplasm of kidney, except renal pelvis, including Hilmo
- Solid cancers, helper endpoint
- Malignant neoplasm
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 367 | 88 | 279 |
| Unadjusted period prevalence (%) | 0.10 | 0.03 | 0.13 |
| Median age at first event (years) | 67.08 | 67.48 | 66.96 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 386
- Matched controls
- 3860
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8260/3-C64.9
ICD-O-3
Papillary adenocarcinoma, NOS, of kidney, NOS
+∞
307.7
386
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
894.4
307.7
323
22
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
307.7
374
*
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
73.5
156.7
86
15
B01AB10
ATC
tinzaparin; parenteral
15.1
130.8
138
137
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
21.1
128.1
106
68
JN4AD
NOMESCO Finland
Body CT examination
14.9
117.1
121
115
WX302
NOMESCO Finland
Thoracal epidural anesthesy
29.9
116.7
81
34
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
10.7
112.1
162
245
KAD00
NOMESCO Finland
Partial nephrectomy
657.2
104.9
99
*
JN4BD
NOMESCO Finland
Extensive body CT
14.4
103.0
106
99
JN4CD
NOMESCO Finland
Very extensive body CT
33.6
91.3
60
21
KA1AE
NOMESCO Finland
Kidney ultrasound examination
20.8
89.9
72
42
KAD01
NOMESCO Finland
Percutaneous endoscopic partial nephrectomy
1050.6
88.3
83
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
+∞
77.8
72
*
TPH07
NOMESCO Finland
Cathetrisation of artery
8.0
77.6
134
240
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
423.7
71.1
69
*
130
Kela drug reimbursment
Malignant tumour
+∞
66.6
62
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
66.6
62
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
19.0
64.6
53
32
WX408
NOMESCO Finland
General anesthesy, balanced
5.7
63.2
190
565
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
15.1
60.1
56
43
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
8.0
55.7
86
133
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
18.5
55.6
46
28
WX402
NOMESCO Finland
General anaesthesia
5.4
53.1
145
389
ZXE20
NOMESCO Finland
More than three and less than five hours
5.6
48.2
116
277
JN3AD
NOMESCO Finland
Abdominal CT examination
6.1
46.4
96
199
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
14.1
46.0
44
35
A11CC03
ATC
alfacalcidol; systemic
13.9
40.6
39
31
B03XA02
ATC
darbepoetin alfa; parenteral
17.7
40.5
34
21
TK800
NOMESCO Finland
Hemodialysis
12.6
38.4
39
34
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
37.1
35
*
R4110
NOMESCO Finland
Physiotherapy
3.7
34.8
169
666
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.7
32.9
260
1381
N02AX02
ATC
tramadol; systemic, rectal
3.6
32.4
242
1237
B01AB05
ATC
enoxaparin; parenteral
3.5
31.2
175
746
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
30.6
29
*
N18.8
ICD-10 Finland
Other chronic renal failure
9.4
28.8
36
42
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.9
26.5
65
153
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
5.1
25.8
60
135
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
25.3
24
*
A03FA01
ATC
metoclopramide; systemic, rectal
4.3
24.5
73
200
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.3
22.8
67
181
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.3
22.7
49
103
197
Kela drug reimbursment
Sunitinib
+∞
22.1
21
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
21.7
22.1
32
16
ZXE10
NOMESCO Finland
More than one and less than three hours
2.8
22.0
176
880
UKC02
NOMESCO Finland
Cystoscopy
3.3
22.0
104
388
WZC30
NOMESCO Finland
Teaching
3.6
21.9
84
274
Z94.0
ICD-10 Finland
Kidney transplant status
46.2
21.7
26
6
Z51.5
ICD-10 Finland
Palliative care
6.6
21.5
36
59
N28.1
ICD-10 Finland
Cyst of kidney
9.5
21.4
26
29
U14
ICPC
Kidney symptom/complaint
19.3
21.3
32
18
U75
ICPC
Malignant neoplasm of kidney
+∞
21.0
20
*
205
Kela drug reimbursment
Chronic hypertension
2.8
21.0
170
851
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
51.0
20.4
24
5
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
28.9
20.3
27
10
ZXD10
NOMESCO Finland
Scheduled procedure
2.6
19.4
182
973
A12AA04
ATC
calcium carbonate; oral
15.2
18.9
31
22
A04AA02
ATC
granisetron; systemic, transdermal
+∞
18.9
18
*
127
Kela drug reimbursment
Transplant complication
25.2
18.9
26
11
WF049
NOMESCO Finland
Radiotherapy of metastasis
199.3
18.7
19
*
V03AE01
ATC
polystyrene sulfonate; oral
22.2
17.5
25
12
R31
ICD-10 Finland
Unspecified haematuria
3.3
17.4
76
267
H02AB02
ATC
dexamethasone; systemic
17.0
17.3
27
17
D30.0
ICD-10 Finland
Benign neoplasm: Kidney
33.2
17.2
22
7
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.8
17.0
40
90
WF002
NOMESCO Finland
Radical radiotherapy
66.4
16.9
19
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
16.8
91
362
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
16.8
16
*
KAC00
NOMESCO Finland
Nephrectomy
+∞
16.8
16
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
16.8
16
*
L01XE04
ATC
[U] sunitinib
+∞
16.8
16
*
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
+∞
16.8
16
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.0
16.7
38
83
L04AA06
ATC
mycophenolic acid; systemic
17.7
16.3
25
15
Z49.1
ICD-10 Finland
Extracorporeal dialysis
14.4
16.2
27
20
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
25.8
16.2
22
9
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.4
15.8
32
63
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
88.8
15.7
17
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
15.6
114
529
KA3LT
NOMESCO Finland
Njurlesion coagulation
166.5
15.6
16
*
C08CA01
ATC
amlodipine; oral
2.4
15.4
204
1240
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
59.1
14.9
17
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
59.1
14.9
17
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.6
14.9
29
55
116
Kela drug reimbursment
Prostate cancer
+∞
14.7
14
*
M04AA01
ATC
allopurinol; systemic
2.8
14.4
88
372
ZXC96
NOMESCO Finland
Robot assisted procedure
31.4
14.0
18
6
WZC00
NOMESCO Finland
Treatment plan or consultation
2.4
14.0
128
656
WX110
NOMESCO Finland
Infiltration anesthesia
2.5
14.0
279
1990
137
Kela drug reimbursment
Uraemia requiring dialysis
24.9
13.9
19
8
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
55.5
13.9
16
*
KA3CT
NOMESCO Finland
Biopsy of kidney under CT guidance
+∞
13.6
13
*
L04AD02
ATC
tacrolimus; systemic
35.4
13.6
17
5
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
144.9
13.5
14
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
19.1
13.5
20
11
H05BX01
ATC
cinacalcet; oral
26.9
13.5
18
7
N02AA05
ATC
oxycodone; systemic
2.8
13.4
79
327
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
4.3
13.2
36
91
J01MA02
ATC
ciprofloxacin; systemic
2.2
13.2
177
1062
L04AA01
ATC
[U] ciclosporin
19.9
13.0
19
10
C08CA02
ATC
felodipine; oral
3.0
12.9
63
235
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.5
12.8
98
460
N18.0
ICD-10 Finland
End-stage renal disease
16.1
12.8
20
13
I10
ICD-10 Finland
Essential (primary) hypertension
2.4
12.7
289
2134
1502
Kela drug reimbursment
Cabozantinib
+∞
12.6
12
*
N02BE01
ATC
paracetamol; systemic, rectal
4.1
12.6
360
2977
S18
ICPC
Laceration/cut
2.2
12.5
206
1332
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.3
12.4
33
82
C02AC05
ATC
moxonidine; oral
3.9
12.2
38
106
196
Kela drug reimbursment
Paricalcitol and cinacalcet
27.7
12.1
16
6
SPAT1153
SPAT
Removal of sutures
2.2
12.0
146
835
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
48.3
12.0
14
*
ZXA05
NOMESCO Finland
Left side
2.3
11.7
121
646
Z3226
NOMESCO Finland
Physiotherapist
2.5
11.7
89
415
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
4.2
11.7
32
81
WW500
NOMESCO Finland
Blood transfusion
9.1
11.7
24
28
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.6
11.6
28
64
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
11.6
96
465
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
11.6
124
671
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
+∞
11.5
11
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
11.5
11
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
11.5
11
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
11.5
11
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
11.5
11
*
KAC01
NOMESCO Finland
Percutaneous endoscopic nephrectomy
+∞
11.5
11
*
J01MA12
ATC
levofloxacin; systemic
2.5
11.5
90
426
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.0
11.4
34
92
ZXE00
NOMESCO Finland
One hour or less
2.1
11.4
159
956
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
17.7
11.3
17
10
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.2
11.2
131
735
GD1AD
NOMESCO Finland
Thorax CT examination
3.8
11.0
35
99
R23.8
ICD-10 Finland
Other and unspecified skin changes
2.5
10.8
75
335
Z49.0
ICD-10 Finland
Preparatory care for dialysis
13.4
10.8
18
14
L04AD01
ATC
ciclosporin; systemic
13.4
10.8
18
14
L02AE02
ATC
leuprorelin; implant, parenteral
61.7
10.7
12
*
322
Kela drug reimbursment
Sunitinib
+∞
10.5
10
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
10.5
10
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
10.5
10
*
3012
Kela drug reimbursment
Cabozantinib
+∞
10.5
10
*
UJF32
NOMESCO Finland
Coloscopy
2.2
10.4
114
620
C03CA01
ATC
furosemide; systemic
2.1
10.4
143
849
321
Kela drug reimbursment
Paricalcitol and cinacalcet
24.1
10.3
14
6
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
4.4
10.3
26
62
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.2
10.2
28
71
B01AB04
ATC
dalteparin; parenteral
4.5
10.2
25
58
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
15.1
10.1
16
11
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.8
10.0
31
86
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
41.2
10.0
12
*
V03AE02
ATC
sevelamer; oral
26.8
9.9
13
5
B05DA
ATC
Isotonic solutions
20.7
9.9
14
7
G04CA02
ATC
tamsulosin; oral
2.0
9.8
157
981
Z2221
NOMESCO Finland
Medical doctor
2.1
9.8
112
618
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
11.8
9.7
17
15
WX306
NOMESCO Finland
Lumbar epidural anesthesy
4.7
9.4
22
49
159
Kela drug reimbursment
Pazopanib
+∞
9.4
9
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
9.4
9
*
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
22.3
9.4
13
6
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.5
9.2
62
272
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
9.1
133
801
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
37.6
9.1
11
*
B03XA01
ATC
erythropoietin; parenteral
37.6
9.1
11
*
M05BX04
ATC
denosumab; parenteral
4.0
8.9
26
69
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
14.5
8.8
14
10
D64.9
ICD-10 Finland
Anaemia, unspecified
2.6
8.7
55
233
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.7
8.7
49
196
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
51.2
8.7
10
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.3
8.6
33
106
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
20.6
8.5
12
6
C09AA02
ATC
enalapril; systemic
2.1
8.5
102
570
TPX10
NOMESCO Finland
Implantation of vascular injection port
8.2
8.5
18
23
XX9XW, ,
NOMESCO Finland
92.0
8.4
9
*
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
13.2
8.4
14
11
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
13.2
8.4
14
11
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.1
8.4
37
129
A79
ICPC
Malignancy NOS
+∞
8.4
8
*
KB1CG
NOMESCO Finland
Extensive MRI examination of urinary tract with high intensity magnet
+∞
8.4
8
*
L01EX07
ATC
cabozantinib; oral
+∞
8.4
8
*
C64.80
ICD-10 Finland
Wilms tumour
+∞
8.4
8
*
158
Kela drug reimbursment
Everolimus
+∞
8.4
8
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
8.4
8
*
ZX120
NOMESCO Finland
Intravenous
3.2
8.3
33
108
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
14.9
8.3
13
9
Z49.2
ICD-10 Finland
Other dialysis
14.9
8.3
13
9
Z31.5
ICD-10 Finland
Genetic counselling
7.5
8.1
18
25
C09BA02
ATC
enalapril and diuretics; systemic
2.7
8.0
45
180
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.2
8.0
77
394
N19
ICD-10 Finland
Unspecified kidney failure
3.7
7.8
25
71
XKD00
NOMESCO Finland
Uroflowmetry
2.1
7.8
83
441
A02BC02
ATC
pantoprazole; systemic
1.9
7.8
264
2056
Z3231
NOMESCO Finland
Registered nurse
2.0
7.6
110
653
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
25.6
7.6
10
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.7
7.5
24
68
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
81.6
7.4
8
*
Y77
ICPC
Malignant neoplasm prostate
81.6
7.4
8
*
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
81.6
7.4
8
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
7.4
52
232
R4190
NOMESCO Finland
Nutritional therapy
6.0
7.3
19
33
L01XE11
ATC
[U] pazopanib
+∞
7.3
7
*
168
Kela drug reimbursment
Axitinib
+∞
7.3
7
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
7.3
7
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
7.3
7
*
H02AB04
ATC
methylprednisolone; systemic
2.2
7.2
64
316
ZXA00
NOMESCO Finland
Right side
1.9
7.1
118
733
UJF30
NOMESCO Finland
Ileoscopy through colon
2.5
7.0
44
186
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.5
6.9
24
72
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
14.1
6.9
11
8
B05DB
ATC
Hypertonic solutions
14.1
6.9
11
8
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
8.5
6.9
14
17
Z2446
NOMESCO Finland
Social worker
2.9
6.8
32
116
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
6.6
74
399
A04
ICPC
Weakness/tiredness general
2.2
6.6
60
299
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
10.3
6.6
12
12
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.4
6.5
16
26
C07AB02
ATC
metoprolol; systemic
1.9
6.5
94
556
NK6AN
NOMESCO Finland
Total body bone isotope imaging
71.0
6.4
7
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
71.0
6.4
7
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
71.0
6.4
7
*
M10.9
ICD-10 Finland
Gout, unspecified
2.4
6.4
45
200
C07AG02
ATC
carvedilol; oral
2.7
6.4
35
138
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
8.4
6.4
13
16
N03AX16
ATC
[U] pregabalin
1.9
6.4
93
551
WX704
NOMESCO Finland
Intubation
2.7
6.3
35
139
WX290
NOMESCO Finland
Other blockage of nerve
1.7
6.3
154
1066
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
18.4
6.3
9
5
V03AE03
ATC
lanthanum carbonate; oral
18.4
6.3
9
5
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
6.3
6
*
L01XE26
ATC
[U] cabozantinib
+∞
6.3
6
*
L01XE17
ATC
[U] axitinib
+∞
6.3
6
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
6.3
6
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
6.3
6
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.3
6.3
23
72
ZX090
NOMESCO Finland
Other technic of radiotherapy
27.2
6.3
8
*
N20.1
ICD-10 Finland
Calculus of ureter
3.2
6.2
25
83
H02AB06
ATC
prednisolone; systemic
1.7
6.1
178
1289
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
6.1
107
671
C08CA13
ATC
lercanidipine; oral
2.0
6.1
69
374
N30
ICD-10 Finland
Cystitis
3.2
6.0
24
79
C03AA03
ATC
hydrochlorothiazide; oral
2.4
6.0
43
193
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
268
1116
5.58
57.85
6.1
2.9
—
—
—
0
0
288
1302
5.77
55.28
3.5
2.5
—
—
—
0
0
225
839
5.03
55.09
5.9
2.8
0.19
0.38
e6/l
2.05
193
622
236
927
4.98
53.69
6.2
2.9
22.53
124.67
e6/l
0.81
204
700
95
173
6.96
52.76
9.0
10.0
22.97
24.74
mmol/l
7.90
95
168
119
276
5.79
51.31
13.2
7.1
12.27
10.80
mmol/l
1.28
113
261
275
1254
5.15
50.58
9.2
4.0
34.76
35.59
g/l
1.48
258
1154
190
657
4.73
50.32
2.9
2.3
—
—
—
0
0
147
426
4.96
48.52
9.9
6.6
104.60
104.28
mmol/l
0.39
147
426
178
617
4.50
46.28
4.6
2.2
2.84
3.55
e6/l
0.68
167
543
155
497
4.54
44.42
4.8
2.9
0.74
1.42
e6/l
1.03
89
279
275
1335
4.69
44.41
15.4
5.8
1.20
1.20
mmol/l
0.12
259
1208
135
396
4.70
43.29
15.9
5.7
1.11
1.01
mmol/l
2.55
129
361
158
526
4.39
42.84
4.5
2.7
0.45
1.00
e6/l
3.04
93
305
96
217
5.56
41.97
9.7
4.4
162.97
96.42
ng/l
3.99
89
194
132
404
4.45
39.66
9.4
8.5
-1.17
1.41
mmol/l
12.78
117
317
350
2297
6.62
32.42
12.7
5.5
81.28
75.09
u/l
2.45
339
2116
266
1457
3.66
31.59
17.4
6.3
1.21
1.21
mmol/l
0.05
229
1278
61
139
5.02
25.82
3.4
1.4
3.16
2.68
ug/l
0.34
50
100
270
1608
3.26
25.60
10.5
5.9
4.66
4.37
e9/l
0.86
227
1412
185
916
2.96
24.07
4.8
2.1
2.37
2.34
mmol/l
1.02
161
754
297
1910
3.41
23.90
8.2
4.7
6.81
6.82
mmol/l
0.04
290
1793
250
1469
2.99
23.43
8.2
4.0
10.69
12.58
umol/l
2.11
239
1390
260
1570
3.01
22.99
17.9
16.8
1.19
1.36
inr
2.24
66
432
105
395
3.28
21.86
6.8
2.5
20.77
24.68
%
2.61
91
334
61
161
4.31
21.39
8.2
3.7
23.52
24.64
mmol/l
2.21
61
156
107
414
3.19
21.19
6.6
2.5
2.16
2.23
g/l
0.57
99
387
126
545
2.95
20.43
3.5
2.1
2.47
2.43
mmol/l
2.42
105
458
110
472
2.86
17.80
6.5
2.4
10.88
13.45
umol/l
4.04
103
435
170
915
2.53
17.38
4.4
2.5
392.59
7142.45
umol/l
3.42
153
792
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
43
104
4.53
16.75
2.1
2.6
0.30
0.36
u/ml
0.55
15
57
103
447
2.78
16.15
4.2
2.9
0.80
0.83
mmol/l
1.22
97
416
84
333
2.95
15.54
8.4
3.3
5.71
5.82
kpa
0.47
84
322
217
1371
2.33
14.76
7.0
5.5
23.18
26.56
%
4.58
201
1298
83
336
2.87
14.73
8.4
3.3
0.83
2.32
mmol/l
3.79
75
282
214
1365
2.27
13.96
6.9
5.4
61.71
58.07
%
4.29
200
1296
69
260
3.01
13.88
2.9
2.0
40.63
49.99
u/l
0.22
63
213
45
142
3.46
12.08
1.9
1.6
1.94
1.52
g/l
1.32
37
125
157
937
2.14
11.48
3.1
2.3
59.28
61.69
u/l
0.18
142
872
297
2276
2.32
11.10
5.4
3.9
16.93
11.52
mm/h
3.99
273
2075
21
39
5.64
10.99
1.1
1.2
—
—
—
0
0
174
1130
1.98
9.69
5.6
2.6
202.45
152.99
ug/l
1.00
167
1033
177
1159
1.97
9.60
4.9
3.2
7.19
8.28
mmol/l
3.78
149
966
126
732
2.07
9.57
2.5
2.1
3.25
2.95
mg/l
0.64
112
615
359
3078
3.38
9.41
28.8
13.2
38.54
25.54
mg/l
6.75
329
2361
27
71
4.01
9.40
1.9
1.4
—
—
—
0
0
97
513
2.19
9.38
2.3
1.8
—
—
—
0
0
208
1459
1.92
9.02
4.7
3.3
0.00
0.00
estimate
0.50
47
241
171
1125
1.93
8.99
3.3
2.2
80.35
77.11
nmol/l
0.71
153
980
62
275
2.49
8.96
5.7
2.8
5.07
4.65
kpa
0.77
62
263
55
233
2.59
8.74
4.1
2.0
40.06
63.97
ml/min/173m2
6.19
34
91
176
1199
1.86
8.08
5.8
3.8
26.89
8.12
mg/mmol
3.56
135
799
11
5
22.58
8.06
10.5
7.0
5.57
5.30
mmol/l
—
11
5
207
1486
1.85
8.01
4.9
3.3
0.00
0.01
estimate
0.50
47
212
64
303
2.33
7.99
2.7
2.3
8.59
7.89
umol/l
0.11
56
271
35
122
3.06
7.98
2.3
1.4
—
—
—
0
0
20
33
6.33
7.95
3.7
2.2
—
387.40
—
0
5
204
1462
1.84
7.90
6.3
4.5
0.00
0.00
estimate
-0.00
47
223
72
375
2.13
7.10
2.2
1.9
—
—
—
0
0
72
376
2.12
7.05
2.1
1.8
—
—
—
0
0
112
688
1.88
6.92
4.4
3.9
210.73
555.56
ng/l
1.11
102
573
46
206
2.40
6.48
2.2
1.6
—
—
—
0
0
21
61
3.58
6.38
1.4
1.4
—
—
—
0
0
21
61
3.58
6.38
1.4
1.4
—
—
—
0
0
18
47
3.97
6.33
1.4
1.0
—
—
—
0
0
18
36
5.19
6.26
1.4
1.4
—
—
—
0
0
25
84
3.11
6.07
2.2
1.4
—
—
—
0
0
61
316
2.11
6.07
4.6
2.8
—
—
—
0
0
185
1365
1.68
5.87
2.2
2.0
98.22
93.96
pmol/l
0.43
97
721
42
190
2.36
5.79
1.5
1.5
—
—
—
0
0
366
3323
2.96
5.72
39.0
16.2
139.06
139.78
mmol/l
6.13
357
3233
366
3334
2.89
5.47
39.7
16.3
4.10
4.02
mmol/l
5.71
357
3241
337
2974
2.05
5.32
30.2
12.0
62.53
77.54
ml/min/173m2
20.08
309
2421
5
0
+∞
5.22
5.6
0.0
54.20
—
ug/min
—
5
0
15
32
4.83
5.04
3.0
1.9
—
—
—
0
0
40
195
2.17
4.64
1.6
1.4
—
—
—
0
0
18
60
3.10
4.46
1.3
1.5
—
—
—
0
0
146
1071
1.58
4.41
2.8
2.9
2889.19
1408.38
ng/l
1.27
128
910
116
810
1.62
4.29
1.9
1.5
19.13
20.25
nmol/l
0.34
109
683
13
29
4.60
4.28
1.0
1.5
—
—
—
0
0
20
73
2.83
4.25
1.5
1.5
—
—
—
0
0
14
41
3.51
4.22
1.1
1.5
—
—
—
0
0
25
104
2.50
4.15
2.5
1.8
0.38
1.56
ug/l
1.40
19
95
40
204
2.07
4.15
5.0
4.1
0.70
1.88
mmol/l
1.27
32
159
18
63
2.95
4.12
1.3
1.5
—
—
—
0
0
8
10
8.14
4.08
1.0
1.4
—
—
—
0
0
13
31
4.30
4.05
1.2
1.5
—
—
—
0
0
15
48
3.21
3.97
1.2
1.3
—
—
—
0
0
23
97
2.46
3.72
1.3
1.3
—
—
—
0
0
8
12
6.78
3.69
1.4
1.3
199.13
41.06
u/l
—
8
12
8
12
6.78
3.69
1.4
1.3
246.88
115.34
u/l
—
8
12
11
25
4.50
3.65
1.1
1.2
—
—
—
0
0
18
68
2.73
3.61
1.4
1.5
—
—
—
0
0
18
68
2.73
3.61
1.3
1.8
—
—
—
0
0
16
57
2.89
3.56
2.3
2.4
15.80
16.61
%
—
9
27
238
2006
1.49
3.47
3.7
3.1
55.56
49.90
u/l
0.53
220
1866
46
266
1.83
3.34
2.8
1.7
410.34
362.49
nmol/l
1.00
41
241
13
38
3.50
3.34
1.1
1.3
—
—
—
0
0
13
38
3.50
3.34
1.2
1.4
—
—
—
0
0
92
642
1.57
3.33
1.6
1.6
1.19
1.39
mg/l
0.45
72
501
229
1925
1.47
3.32
5.2
3.8
2.16
1.90
ug/l
1.03
216
1726
142
1089
1.48
3.30
3.4
2.7
0.77
0.72
ug/l
0.36
113
728
13
43
3.09
3.28
1.5
1.5
—
—
—
0
0
13
43
3.09
3.28
1.5
1.5
—
—
—
0
0
360
3364
2.04
3.18
16.1
9.1
25.18
27.28
u/l
2.19
346
3228
17
68
2.57
3.08
1.5
1.4
326.20
314.40
ug/g
—
10
43
8
16
5.08
3.06
1.8
1.1
—
—
—
0
0
10
26
3.92
3.00
1.1
1.5
—
—
—
0
0
25
124
2.09
2.83
1.4
1.6
—
136.67
—
0
6
10
28
3.64
2.80
1.1
1.5
—
—
—
0
0
5
6
8.42
2.75
1.0
1.0
—
—
—
0
0
11
34
3.30
2.75
5.0
2.4
—
—
—
0
0
27
142
1.97
2.63
6.1
4.6
24.31
24.92
mmol/l
0.43
21
133
366
3473
2.04
2.56
46.8
19.1
39.03
40.98
%
9.02
341
3201
24
123
2.01
2.51
2.5
3.3
—
—
—
0
0
366
3476
2.02
2.50
45.6
19.0
250.57
236.80
e9/l
3.25
359
3374
7
16
4.43
2.48
1.3
1.4
12.14
13.60
ug/l
—
7
16
366
3477
2.02
2.48
45.6
19.0
4.36
4.59
e12/l
10.64
357
3354
8
21
3.87
2.47
1.3
1.2
—
—
—
0
0
8
21
3.87
2.47
1.3
1.2
—
—
—
0
0
8
21
3.87
2.47
1.3
1.2
—
—
—
0
0
12
45
2.72
2.47
2.4
2.8
64.08
58.62
%
1.15
12
45
16
71
2.31
2.37
1.6
1.2
—
—
—
0
0
17
79
2.20
2.28
1.4
3.2
27.17
34.90
umol/l
1.01
12
73
307
2816
1.44
2.20
4.8
4.1
2.12
1.99
mu/l
0.33
280
2549
6
14
4.34
2.16
1.0
1.1
—
—
—
0
0
6
14
4.34
2.16
1.0
1.1
—
—
—
0
0
139
1133
1.35
2.11
5.1
3.4
—
—
—
0
0
11
43
2.60
2.09
3.1
3.7
—
—
—
0
0
22
119
1.90
2.01
2.4
1.6
—
—
—
0
0
11
45
2.49
1.94
2.4
2.4
5.24
4.58
e9/l
0.47
11
45
112
898
1.35
1.87
1.8
1.7
1.62
1.35
mmol/l
2.24
100
731
5
12
4.21
1.83
1.4
1.2
—
—
—
0
0
5
12
4.21
1.83
1.4
1.2
—
—
—
0
0
26
154
1.74
1.81
1.7
1.8
—
—
—
0
0
9
35
2.61
1.81
1.0
1.4
—
—
—
0
0
12
54
2.26
1.75
1.1
1.3
—
—
—
0
0
5
13
3.88
1.72
1.0
1.2
—
—
—
0
0
20
112
1.83
1.68
4.0
2.1
196.59
83.41
ug/min
0.47
15
65
186
1622
1.28
1.65
3.0
2.4
—
—
—
0
0
244
2203
1.29
1.64
4.1
3.3
14.90
14.97
pmol/l
0.13
218
1976
8
32
2.53
1.60
1.5
1.5
—
—
—
0
0
8
32
2.53
1.60
1.5
1.5
—
—
—
0
0
179
1564
1.27
1.53
4.5
3.7
24.08
23.86
%
0.07
96
715
13
65
2.03
1.50
1.5
1.7
—
—
—
0
0
19
109
1.78
1.49
2.3
1.5
—
—
—
0
0
9
38
2.40
1.46
1.3
1.2
—
—
—
0
0
79
623
1.34
1.46
1.8
1.8
1424.09
1124.57
nmol/l
0.67
59
477
7
28
2.53
1.46
1.0
1.7
—
—
—
0
0
27
173
1.60
1.44
7.4
3.5
51.62
51.43
%
0.01
27
168
68
526
1.36
1.42
1.3
1.2
1.61
1.46
u/ml
0.06
14
142
28
183
1.57
1.39
7.2
2.8
24.27
25.29
mmol/l
0.99
28
178
47
344
1.42
1.37
1.2
1.3
—
—
—
0
0
5
17
2.97
1.36
1.2
1.8
783.00
692.41
u/ml
—
5
17
6
24
2.52
1.31
1.0
1.1
—
—
—
0
0
124
1057
1.26
1.26
2.2
2.2
130.37
298.23
u/l
1.62
118
982
26
172
1.55
1.24
1.8
1.9
—
—
—
0
0
21
132
1.62
1.23
1.8
1.9
34.00
39.12
u/l
0.47
21
116
8
37
2.19
1.22
1.1
1.1
—
—
—
0
0
5
19
2.65
1.22
1.4
1.4
—
—
—
0
0
18
109
1.68
1.21
1.1
1.0
—
—
—
0
0
5
20
2.52
1.15
1.4
1.3
—
—
—
0
0
5
20
2.52
1.15
1.0
1.5
—
—
—
0
0
151
1330
1.22
1.12
4.1
3.9
52.90
98.98
ng/l
0.60
115
1000
11
59
1.89
1.08
1.9
1.8
229.91
276.66
mu/l
0.41
11
53
11
60
1.86
1.04
1.0
1.2
—
1.16
—
0
5
15
93
1.64
0.95
1.9
1.4
0.26
0.24
g/l
0.43
15
88
6
27
2.24
0.94
1.0
1.3
—
—
—
0
0
6
27
2.24
0.94
1.0
1.3
—
—
—
0
0
6
27
2.24
0.94
1.0
1.3
—
—
—
0
0
6
27
2.24
0.94
1.0
1.3
—
—
—
0
0
6
27
2.24
0.94
1.0
1.3
—
—
—
0
0
6
27
2.24
0.94
1.0
1.3
—
—
—
0
0
12
70
1.74
0.93
1.2
1.4
10.64
4.98
u/l
0.71
12
55
6
28
2.16
0.92
1.2
1.7
—
—
—
0
0
6
29
2.09
0.89
1.8
2.4
—
—
—
0
0
339
3273
1.29
0.89
5.8
5.5
2.46
2.62
mmol/l
2.57
307
3021
11
64
1.74
0.87
1.0
1.2
—
—
—
0
0
15
96
1.59
0.85
1.9
1.4
1.21
1.14
g/l
0.41
15
90
332
3203
1.26
0.83
5.2
4.9
4.32
4.44
mmol/l
1.30
301
2969
321
3086
1.24
0.83
7.8
6.4
40.65
40.73
mmol/mol
0.05
292
2857
90
780
1.20
0.77
6.3
3.4
0.05
0.01
estimate
0.30
42
218
7
38
1.86
0.74
3.3
3.1
—
27.82
—
0
11
326
3158
1.21
0.65
5.3
4.9
6.23
6.09
mmol/l
0.74
289
2869
5
29
1.73
0.64
1.0
1.0
—
—
—
0
0
0
21
0.00
0.60
0.0
2.5
—
—
—
0
0
11
72
1.54
0.59
1.0
1.2
—
2.90
—
0
10
317
3072
1.18
0.58
4.6
4.3
1.51
1.32
mmol/l
3.79
274
2811
11
73
1.52
0.56
1.0
1.2
—
3.44
—
0
13
17
124
1.39
0.56
1.2
1.2
103.40
147.06
iu/ml
—
5
49
49
417
1.20
0.53
5.0
4.8
30.15
31.81
%
0.53
34
286
326
3173
1.18
0.52
5.2
4.8
1.30
1.37
mmol/l
2.49
295
2921
43
362
1.21
0.52
2.6
2.7
5.72
8.33
ug/l
1.01
37
320
12
87
1.39
0.42
1.2
2.3
—
—
—
0
0
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
137.97
—
0
17
38
440
0.85
0.40
1.3
1.3
28.35
8.70
u/ml
0.48
11
163
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
14
109
1.30
0.34
1.3
1.2
—
—
—
0
0
18
220
0.81
0.33
2.0
1.8
—
—
—
0
0
38
333
1.16
0.32
2.0
2.4
12.16
15.14
nmol/l
1.88
31
296
7
53
1.33
0.31
1.0
1.1
—
—
—
0
0
10
77
1.31
0.26
1.3
1.1
—
—
—
0
0
10
77
1.31
0.26
1.3
1.1
—
—
—
0
0
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
57.62
—
0
11
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
5
43
1.16
0.21
1.0
1.0
1.73
1.56
g/l
—
5
38
10
82
1.23
0.17
1.3
1.4
—
—
—
0
0
5
70
0.71
0.17
1.0
1.1
—
—
—
0
0
44
470
0.93
0.15
1.2
1.3
126.38
35.73
iu/ml
0.79
12
128
47
441
1.07
0.14
13.1
7.2
—
—
—
0
0
13
146
0.89
0.10
1.5
1.9
40.77
40.94
nmol/l
0.01
13
139
14
155
0.90
0.09
1.9
1.3
—
—
—
0
0
5
64
0.78
0.08
1.0
1.3
—
—
—
0
0
74
719
1.04
0.07
2.0
1.7
460.57
6723102.08
pmol/l
0.50
61
595
19
180
1.06
0.04
1.2
1.4
—
49.30
—
0
12
22
210
1.05
0.03
2.6
2.6
—
12.14
—
0
10
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_KIDNEY_PAPILLARYADENO – Adenocarcinoma and Papillary adenocarcinoma of kidney
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).